Skip to content

Effects of using the drug - misoprostol through different routes for induction of labour on the cesarean delivery rates.

Sequential use of oral and vaginal misoprostol versus oral or vaginal misoprostol alone for Induction of labor and the caesarean delivery risk – A retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036652
Enrollment
756
Registered
2021-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Control Intervention1: Not Applicable: Not Applicable Control Intervention2: Oral Misoprostol: B. Oral misoprostol 25 mcg taken orally repeated every 2 hours up to a maximum of 5 doses Control Interve

Sponsors

Dept Of Obstetrics And Gynecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Singleton with Cephalic presentation • Nulliparous and multiparous women who had completed 36 weeks of gestation • Modified Bishop’s score • Normal fetal heart tracing available prior to induction

Exclusion criteria

Exclusion criteria: 1. Documented Cephalopelvic disproportion 2. Prior caesarean delivery/ previous scarring on the uterus 3. Signs of labour (regular painful contractions with cervical change) 4. Fetal demise or known major fetal anomaly 5. Antepartum haemorrhage 6. Cerclage in the current pregnancy 7. Oligohydramnios, defined as amniotic fluid index 8. Fetal growth restriction, defined as EFW 9. Chronic medical disorders i.e., chronic hypertension, pregestational diabetes mellitus, renal diseases

Design outcomes

Primary

MeasureTime frame
To assess the proportions of caesarean deliveries with the use of misoprostol through three methodsTimepoint: After delivery

Secondary

MeasureTime frame
i. Time from induction to vaginal delivery, ii. Incidence of Pathological CTG iii. Indications for cesarean delivery, iv. Uterine hyperstimulation v. Maternal Post-partum hemorrhage, vi. Puerperal Pyrexia vii. Number of sterile vaginal examinations performed viii. Duration and dose of oxytocin augmentation required ix. Change in neonatal cord blood gases at birth x. Unplanned admission to the NICU Timepoint: before and after delivery

Countries

India

Contacts

Public ContactDr Anu Anna George

MOSC MEDICAL COLLEGE HOSPITAL

annamed013@gmail.com09539748095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026